과제정보
This research was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (NRF-2017R1A2B4002072). The data that support the findings of this study are available from the corrresponding author upon reasonable request and the experiments complied with the current laws of this country.
참고문헌
- World Health Organization. Report on Global Sexually Transmitted Infection Surveillance [internet]. Geneva, Switzerland: World Health Organization. 2018. Arailable from: https://www.who.int/reproductivehealth/publications/stis-surveillance-2018/en.
- Menezes CB, Frasson AP, Tasca T. Trichomoniasis - are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide? Microb Cell 2016; 3: 404-419. https://doi.org/10.15698/mic2016.09.526
- Skerka V, Schonwald S, Krhen I, Leo M, Ante B, Natasa-Sterk K, Vladimira K, Adriana V. Aetiology of chronic prostatitis. Int J Antimicrob Agents 2002; 19: 471-474. https://doi.org/10.1016/S0924-8579(02)00087-0
- Lee JJ, Moon HS, Lee TY, Hwang HS, Ahn MH, Ryu JS. PCR for diagnosis of male Trichomonas vaginalis infection with chronic prostatitis and urethritis. Korean J Parasitol 2012; 50: 157-159. https://doi.org/10.3347/kjp.2012.50.2.157
- Mitteregger D, Aberle SW, Makristathis A, Walochnik J, Brozek W, Marberger M, Kramer G. High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue. Med Microbiol Immunol 2012; 201: 113-116. https://doi.org/10.1007/s00430-011-0205-2
- Gardner Jr WA, Culberson DE, Bennett BD. Trichomonas vaginalis in the prostate gland. Arch Pathol Lab Med 1986; 110: 430-432.
- Sutcliffe S, Neace C, Magnuson NS, Reeves R, Alderete JF. Trichomonosis, a common curable STI, and prostate carcinogenesis - a proposed molecular mechanism. PLoS Pathog 2012;8 e1002801. https://doi.org/10.1371/journal.ppat.1002801
- Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor AS, Giovannucci EL, Platz EA, Sutcliffe S, Fall K, Kurth T, Ma J, Stampfer MJ, Mucci LA. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J Natl Cancer Inst 2009; 101: 1406-1411. https://doi.org/10.1093/jnci/djp306
- Sutcliffe S, Giovannucci E, Alderete JF, Chang T, Gaydos CA, Zenilman JM, De Marzo AM, Willett WC, Platz EA. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 939-945. https://doi.org/10.1158/1055-9965.EPI-05-0781
- Sutcliffe S, Alderete JF, Till C, Goodman PJ, Hsing AW, Zenilman JM, De Marzo AM, Platz EA. Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial. Int J Cancer 2009; 124: 2082-2087. https://doi.org/10.1002/ijc.24144
- Caini S, Gandini S, Dudas M, Bremer V, Severi E, Gherasim A. Sexually transmitted infections and prostate cancer risk: a systematic review and meta-analysis. Cancer Epidemiol 2014; 38: 329-338. https://doi.org/10.1016/j.canep.2014.06.002
- Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology 2002;16: 217-226.
- Kamp DW, Shacter E, Weitzman SA. Chronic inflammation and cancer: the role of the mitochondria. Oncology 2011; 25: 400-410.
- Ha NH, Park DG, Woo BH, Kim DJ, Choi JI, Park BS, Kim YD, Lee JH, Park HT. Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs. Cytokine 2016; 86: 64-72. https://doi.org/10.1016/j.cyto.2016.07.013
- Simons BW, Durham NM, Bruno TC, Grosso JF, Schaeffer AJ, Ross AE, Hurley PJ, Berman DM, Drake CG, Thumbikat P, Schaeffer EM. A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression. J Pathol 2015; 235: 478-489. https://doi.org/10.1002/path.4472
- Xu Y, Li H, Chen W, Yao X, Xing Y, Wang X, Zhong J, Meng G. Mycoplasma hyorhinis activates the NLRP3 inflammasome and promotes migration and invasiveness of gastric cancer cells. PLoS One 2013; 8: e77955. https://doi.org/10.1371/journal.pone.0077955
- Twu O, Dessi D, Vu A, Mercer F, Stevens GC, de Miguel N, Rappelli P, Cocco AR, Clubb RT, Fiori PL, Johnson PJ. Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses. Proc Natl Acad Sci USA 2014; 111: 8179-8184. https://doi.org/10.1073/pnas.1321884111
- Adekoya TO, Richardson RM. Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis. Int J Mol Sci 2020; 23: 4449. https://doi.org/10.3390/ijms21124449
- Chung HY, Kim JH, Han IH, Ryu JS. Polarization of M2 macrophages by interaction between prostate cancer cells treated with Trichomonas vaginalis and adipocytes. Korean J Parasitol 2020; 58: 217-227. https://doi.org/10.3347/kjp.2020.58.3.217
- Kim JH, Kim SS, Han IH, Sim S, Ahn MH, Ryu JS. Proliferation of prostate stromal cell induced by benign prostatic hyperplasia epithelial cell stimulated with Trichomonas vaginalis via crosstalk with mast cell. Prostate 2016; 76: 1431-1444. https://doi.org/10.1002/pros.23227
- Han IH, Kim JH, Kim SS, Ahn MH, Ryu JS. Signalling pathways associated with IL-6 production and epithelial-mesenchymal transition induction in prostate epithelial cells stimulated with Trichomonas vaginalis. Parasite Immunol 2016; 38: 678-687. https://doi.org/10.1111/pim.12357
- Kim JH, Han IH, Shin SJ, Park SY, Chung HY, Ryu JS. Signaling role of adipocyte leptin in prostate cell proliferation induced by Trichomonas vaginalis. Korean J Parasitol 2021; 59: 235-249. https://doi.org/10.3347/kjp.2021.59.3.235
- Somers KD, Brown RR, Holterman DA, Yousefieh N, Glass WF, Wright jr GL, Schellhammer PF, Qian J, Ciavarra RP. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy. Int J Cancer 2003; 107: 773-780. https://doi.org/10.1002/ijc.11464
- Jang SM, Han H, Jun YJ, Jang SH, Min KW, Sim J, Ahn HI, Lee KH, Jang KS, Paik SS. Clinicopathological significance of CADM4 expression, and its correlation with expression of E-cadherin and Ki67 in colorectal adenocarcinomas. J Clin Pathol 2012; 65: 902-906. https://doi.org/10.1136/jclinpath-2012-200730
- de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer DM. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13: 607-615. https://doi.org/10.1016/S1470-2045(12)70137-7
- Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, longterm foe. Clin Cancer Res 2009; 15: 425-430. https://doi.org/10.1158/1078-0432.CCR-08-0149
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 50-70. https://doi.org/10.1016/S0092-8674(00)81683-9
- Mantovani A. Cancer: inflaming metastasis. Nature 2009; 457: 36-37. https://doi.org/10.1038/457036b
- Mantovani A, Garlanda C, Allavavena P. Molecular pathways and targets in cancer-related inflammation. Ann Med 2010; 42: 161-170. https://doi.org/10.3109/07853890903405753
- Nickel JC, Roehrborn CG, O'Leary MP, Bostwick DG, Somerville MC, Rittmaster RS. The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol 2008; 54: 1379-1384. https://doi.org/10.1016/j.eururo.2007.11.026
- de Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7: 256-269. https://doi.org/10.1038/nrc2090
- Frieling JS, Li T, Tauro M, Lynch CC. Prostate cancer-derived MMP3 controls intrinsic cell growth and extrinsic angiogenesis. Neoplasia 2020; 22: 511-521. https://doi.org/10.1016/j.neo.2020.08.004
- Rao SR, Snaith AE, D Marino D, Cheng X, Lwin ST, Orriss IR, Hamdy FC, Edwards CM. Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer. Br J Cancer 2017; 116: 227-236. https://doi.org/10.1038/bjc.2016.402
- Kharmate G, Hosseini-Beheshti E, Caradec J, Chin MY, Tomlinson Guns ES. Epidermal growth factor receptor in prostate cancer derived exosomes. PLoS One 2016; 11: e0154967. https://doi.org/10.1371/journal.pone.0154967
- Cheng WL, Wang CS, Huang YH, Tsai MM, Liang Y, Lin KH. Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasiveness in gastric cancer. Ann Oncol 2011; 22: 2267-2276. https://doi.org/10.1093/annonc/mdq739
- Verbeke H, Struyf S, Laureys G, Van Damme J. The expression and role of CXC chemokines in colorectal cancer. Cytokine Growth Factor Rev 2011; 22: 345-358. https://doi.org/10.1016/j.cytogfr.2011.09.002
- Dhawan P, Richmond A. Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol 2002; 72: 9-18. https://doi.org/10.1189/jlb.72.1.9
- Miyake M, Lawton A, Goodison S, Urquidi V, Rosser CJ. Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer. Pathol Res Pract 2014; 210: 74-78. https://doi.org/10.1016/j.prp.2013.08.013
- Lu Y, Cai Z, Xiao G, Liu Y, Keller ET, Yao Z, Zhang J. CCR2 expression correlates with prostate cancer progression. J Cell Biochem 2007; 101: 676-685. https://doi.org/10.1002/jcb.21220
- Lu Y, Chen Q, Corey E, Xie W, Fan J, Mizokami A, Zhang J. Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone. Clin Exp Metastasis 2009; 26: 161-169. https://doi.org/10.1007/s10585-008-9226-7
- Nguyen DP, Li J, Tewari AK. Inflammation and prostate cancer: the role of interleukin 6 (IL-6). BJU Int 2014; 113: 986-992. https://doi.org/10.1111/bju.12452
- Azevedo A, Cunha V, Teixeira AL, Medeiros R. IL-6/IL-6R as a potential key signaling pathway in prostate cancer development. World J Clin Oncol 2011; 2: 384-396. https://doi.org/10.5306/wjco.v2.i12.384
- Porta C, Riboldi E, Sica A. Mechanisms linking pathogens-associated inflammation and cancer. Cancer Lett 2011; 305: 250-262. https://doi.org/10.1016/j.canlet.2010.10.012
- Kruk J, Aboul-Enein HY. Reactive Oxygen and Nitrogen Species in carcinogenesis: implications of oxidative stress on the progression and development of several cancer types. Mini Rev Med Chem 2017; 17: 904-919. https://doi.org/10.2174/1389557517666170228115324
- Fuste NP, Castelblanco E, Felip I, Santacana M, Fernandes-Hernanadez R, Gatius S, Pedraza N, Pallares J, Cemeli T, Valls J, Rarres M, Ferrezuelo F, Dolcet X, Matias-Guiu X, Gari E. Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer. Oncotarget 2016; 7: 26979-26991. https://doi.org/10.18632/oncotarget.8876
- Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 1993; 7: 331-342. https://doi.org/10.1101/gad.7.3.331
- Li Z, Wang C, Jiao X, Lu Y, Fu M, Quong AA, Dye C, Yang J, Dai M, Zhang X, Li A, Burbelo P, Stanley ER, Pestell RG. Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling. Mol Cell Biol 2006; 26: 4240-4256. https://doi.org/10.1128/MCB.02124-05
- Lo UG, Lee CF, Lee MS, Hsieh JT. The role and mechanism of epithelial-to-mesenchymal transition in prostate cancer progression. Int J Mol Sci 2017; 18: 2079. https://doi.org/10.3390/ijms18102079